Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
2020/10/01 by Theo Vos, Stephen S Lim, Cristiana Abbafati +97 · 121 citations
Medicine · Economics, Econometrics and Finance · #Global Maternal and Child Health #Global Health and Surgery #Health Systems, Economic Evaluations, Quality of Life
paper · pdf · doi:10.1016/s0140-6736(20)30925-9
openalex publication_date 2020/10/01 · openalex created_date 2020/10/22 · openalex updated_date 2026/07/31
Abstract
BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. METHODS: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. FINDINGS: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990-2010 time period, with the greatest annualised rate of decline occurring in the 0-9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10-24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10-24 years were also in the top ten in the 25-49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50-74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. INTERPRETATION: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. FUNDING: Bill & Melinda Gates Foundation.
Cited by
- Global, regional, and national burden of severe periodontitis, 1990–2019: An analysis of the Global Burden of Disease Study 2019
- Treatment of stage <scp>IV</scp> periodontitis: The <scp>EFP S3</scp> level clinical practice guideline
- Health at a Glance 2023
- Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases
- National and regional prevalence of interpersonal violence from others’ alcohol use: a systematic review and modelling study
- Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder
- Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease
- Nutri-Score effectiveness in improving consumers’ nutrition literacy, food choices, health, and healthy eating pattern adherence: A systematic review
- Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort study
- Forecasting the Global Economic and Health Burden of COPD From 2025 Through 2050
- Economic evaluation on dental caries preventive interventions for Australian children using a priority-setting approach
- Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation
- Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation
- Multimodal characterization of cortical amplitude of low-frequency fluctuation alterations in chronic low back pain: integrating functional MRI, transcriptomics, and neurochemical mapping
- Disentangling the effects of nicotine versus non‐nicotine constituents of tobacco smoke on major depressive disorder: A multivariable Mendelian randomisation study
- The neural signature of psychomotor disturbance in depression
- Occupational therapy in pulmonary rehabilitation programs: A scoping review
- Hiperparatireoidismo secundário à hipovitaminose D depende dos níveis séricos de magnésio
- Bundling of unhealthy food products in Johannesburg, South Africa: an exploratory study
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Return to work after acquired brain injury: the influence of executive dysfunction profiles
- The Global Burden of Disease Study at 30 years
- Do antithrombotic drugs have a role in migraine prevention? A systematic review
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
- From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer
- Prevalence of low back pain in professional drivers: a meta-analysis
- Artificial Intelligence Revolutionizes Anti‐Infective Drug Discovery: From Target Identification to Lead Optimization
- Engineering nasally delivered IgM antibodies for respiratory viral infections
- Stressful life events exhibit complex patterns of associations with depressive symptoms in two population-based samples using network analysis
- Health effects associated with consumption of unprocessed red meat: a Burden of Proof study
- Effectiveness and acceptability of exercise treatments for adults with anxiety disorders: a systematic review and network meta-analysis
- Ketone Body Metabolism and Sodium Glucose Cotransporter 2 Inhibitor Response in Heart Failure With Ischemic Cause: A Precision Medicine Approach Using Metabolomics Integration With Global Burden of Disease Population Data Across Diverse Genetic Backgrounds
- Traumatic brain injury: progress and challenges in prevention, clinical care, and research
- Hiring mental health professionals: Evidence from a large-scale policy in Brazil
- The Role of Medical Mistrust in Vaccination Decisions in Rural, Indigenous Namibian Communities
- Cancer statistics in China and United States, 2022: profiles, trends, and determinants
- TopSeg: A Multi-Scale Topological Framework for Data-Efficient Heart Sound Segmentation
- Diet, Sleep, and Physical Activity in Children and Adolescents With Depression: An Umbrella Review of Systematic Reviews
- Macro-Level Correlational Analysis of Mental Disorders: Economy, Education, Society, and Technology Development
- Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
- An<scp>EAACI</scp>review: Go green in health care and research. Practical suggestions for sustainability in clinical practice, laboratories, and scientific meetings
- A systematic review and Meta-Analytic Gaussian Network Aggregation of anxious symptoms
- Emergency department wait time in Newfoundland and Labrador, Canada: Trends and projections of physician initial assessment 2015–2026
- Chronic kidney disease, uremic toxins and microbiota
- Landscape of Aeroallergen Sensitization in Asia
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
- Maternal health planning and prioritization in Chad: developing a supportive tool
- Association between allergic diseases and mental health conditions: An umbrella review
- Economic evaluation of a community dental care model for people experiencing homelessness
- The 7.3 million Australians living with musculoskeletal conditions are not getting the support they deserve
- A comparison of deep multiomics profiles across ethnicity, geography, and age
- Do mammals have menopause?
- A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank
- Chronic back pain and headaches in a nationwide study of the working population in Germany: Prevalence, symptom severity, associated burden, and related demographic and psychosocial factors
- Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission
- Global, Regional, and National Burden of Pulmonary Arterial Hypertension Among Women of Childbearing Age, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021
- Averting wildlife-borne infectious disease epidemics requires a focus on socio-ecological drivers and a redesign of the global food system
- Local homicides increase suicide in US counties
- Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS
- Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV
- Antidepressants for low back pain and spine-related leg pain
- Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries
- Age at School Entry and Human Capital Development: Evidence from Lesotho
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
- Multisession epidural direct current stimulation of the auditory cortex mitigates age-related transcriptomic dysregulation in Wistar rats
- A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity
- Comparing guideline adherence and readability: Artificial intelligence with deep learning versus specialized physicians in peripheral artery disease management
- Global, regional, and national burden of Clostridioides difficile infection (1990–2021) with projections to 2051: A multimodal analysis integrating machine learning (SHAP-XGBoost) and GBD 2021 data
- Accelerometer-Measured Physical Activity and Sedentary Behavior in Individuals With and Without Chronic Diseases: Cross-Sectional Results of 27,890 Adults From the Swedish CArdioPulmonary BioImage Study Cohort
- Estimating the association between Facebook adoption and well-being in 72 countries
- Incidence of Major Depressive Disorder Relapse and Effectiveness of Pharmacologic and Psychological Interventions in Primary Care: A Systematic Review and Meta-Analysis: Incidence de la rechute du trouble dépressif majeur et efficacité des interventions pharmacologiques et psychologiques en soins primaires : revue systématique et méta-analyse
- Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER): design and rationale for a decentralised, real-world cluster-randomised controlled trial and implementation study
- Bending the curve: Modeling the impact of reducing risk factors for noncommunicable diseases to control future health expenditures in Latin America and the Caribbean
- Effectiveness of leading pedestrian intervals for city walkers’ safety
- Plant-Based Diets and Mental and Neurocognitive Health Outcomes: A Systematic Review With Meta-Analysis
- Plant-based diets, genetic predisposition, and the risk of adult-onset asthma A prospective study
- Volume and Intensity of Walking and Risk of Chronic Low Back Pain
- Examining the overlap in lymphatic filariasis prevalence and malaria insecticide-treated net access-use in endemic Africa
- Global Burden and Inequality of Dental Caries, 1990 to 2019
- Genetically modified foods and human health: a comprehensive review and cross-national time-trend analysis
- Socioeconomics and attributable etiology of primary liver cancer, 1990-2019
- Global Well-Being and Mental Health in the Internet Age
- Income and work loss in patients with Addison's disease: a nationwide population-based study
- Contingency management to promote treatment engagement in comorbid alcohol use disorder and alcohol‐related liver disease: Findings from a pilot randomized controlled trial
- Population-Based Estimates of Hepatitis E Virus–Associated Mortality in Bangladesh
- Exploring the associations between the presence, characteristics, and biopsychosocial covariates of pain and lifetime depression in adolescents: A cross-sectional ABCD study analysis
- Sex differences in the intention and decision to use emergency medical services for acute coronary syndrome in Australia: a retrospective study
- Temporal Decomposition Analysis of Noncommunicable Disease Burden: The Interplay of Population Aging, Population Growth, and Low Physical Activity, 2010–2019
- Triangulated evidence provides no support for bidirectional causal pathways between diet/physical activity and depression/anxiety
- Continuity of care and mortality in patients with type 2 diabetes: a cohort study
- Economic optimization of <i>Wolbachia</i> ‐infected <i>Aedes aegypti</i> release to prevent dengue
- Childhood trajectories of emotional and behavioral difficulties are related to polygenic liability for mood and anxiety disorders
- Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015–19: a modelling study (Thanzi La Onse)
- <scp>MAIT</scp> Cells Suppress <scp>IgE</scp> ‐Mediated Asthma via <scp>IFNγ</scp> ‐Dependent B Cell Regulation
- Atlas of the plasma proteome in health and disease in 53,026 adults
- Pharmacokinetic and pharmacological characterization of novel agmatine-based antihyperalgesic compounds
- The development of a patient-reported outcome measuring opioid use disorder financial toxicity: Establishing content validity and reliability
- The diamond minutes: rethinking the earliest link of the trauma chain of survival
- System-Wide Investments Enhance HIV, TB and Malaria Control in Malawi and Deliver Greater Health Impact
- Rice and beans: the nutritious, sustainable and affordable staple of the Brazilian diet
- Clinicians’ perceptions of the Australian Paediatric Mental Health Service System: Problems and solutions
- Educating women to prevent and treat low back and pelvic girdle pain during and after pregnancy: a systematized narrative review
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- Amygdala-centered mechanisms of pain amplification and chronification in fibromyalgia and migraine: Narrative review
- Artificial intelligence-driven exercise programmes in personalising the management of multimorbidity
- Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study
- Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action
- Heart Disease and Stroke Statistics—2021 Update
- The global macroeconomic burden of diabetes mellitus
- Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
- A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults
- Index of multiple deprivation contributed to common psychiatric disorders: A systematic review and comprehensive analysis
- The Heart of the World
- Genetically proxied inhibition of lipid-lowering drug targets and risk of low back pain: A Mendelian randomization study
- 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Defining end of life in dementia: A systematic review
- The WHO estimates of excess mortality associated with the COVID-19 pandemic
Related
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- Benchmarking progress in non-communicable diseases: a global analysis of cause-specific mortality from 2001 to 2019
- Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021